Study Overview
Sex: All
Age: 18 Years / N/A
No Study Documents
Study Overview
Sex: All
Age: 18 Years / N/A
No Study Documents
Completed
Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab
Beigene Study ID
ClinicalTrials.gov ID
China Drug Trials ID
Sex: All
Age: 18 Years / N/A
No Study Documents
Sex: All
Age: 18 Years / N/A
No Study Documents